| Year |
Citation |
Score |
| 2019 |
Jiang L, Tolani B, Yeh CC, Fan Y, Reza JA, Horvai AE, Xia E, Kratz JR, Jablons DM, Mann MJ. Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma. Cancer Management and Research. 11: 8209-8218. PMID 31686913 DOI: 10.2147/Cmar.S218676 |
0.348 |
|
| 2018 |
Tolani B, Hoang NT, Acevedo LA, Leprieur EG, Li H, He B, Jablons DM. Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog. Oncotarget. 9: 14311-14323. PMID 29581846 DOI: 10.18632/Oncotarget.24510 |
0.355 |
|
| 2018 |
Tolani B, Acevedo LA, Hoang NT, He B. Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications. International Journal of Molecular Sciences. 19. PMID 29342862 DOI: 10.3390/Ijms19010238 |
0.369 |
|
| 2017 |
Leprieur EG, Tolani B, Li H, Leguay F, Hoang NT, Acevedo LA, Jin JQ, Tseng HH, Yue D, Kim IJ, Wislez M, Wang C, Jablons DM, He B. Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer. Oncotarget. 8: 103744-103757. PMID 29262597 DOI: 10.18632/Oncotarget.21781 |
0.393 |
|
| 2016 |
Li H, Yue D, Jin JQ, Woodard GA, Tolani B, Luh TM, Giroux-Leprieur E, Mo M, Chen Z, Che J, Zhang Z, Zhou Y, Wang L, Hao X, Jablons D, et al. Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. Oncotarget. PMID 27533453 DOI: 10.18632/Oncotarget.11246 |
0.344 |
|
| 2016 |
Gopalakrishnan R, Matta H, Tolani B, Triche T, Chaudhary PM. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. Oncogene. 35: 1797-810. PMID 26119939 DOI: 10.1038/Onc.2015.245 |
0.436 |
|
| 2015 |
Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh TW, Yang C, Tseng HK, Giroux-Leprieur E, et al. EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. Plos One. 10: e0132134. PMID 26132438 DOI: 10.1371/Journal.Pone.0132134 |
0.312 |
|
| 2014 |
Tolani B, Matta H, Gopalakrishnan R, Punj V, Chaudhary PM. NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process. Journal of Virology. 88: 6345-54. PMID 24672029 DOI: 10.1128/Jvi.00028-14 |
0.568 |
|
| 2014 |
Tolani B, Gopalakrishnan R, Punj V, Matta H, Chaudhary PM. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors. Oncogene. 33: 2928-37. PMID 23792448 DOI: 10.1038/Onc.2013.242 |
0.47 |
|
| 2014 |
Gopalakrishnan R, Matta H, Tolani B, Triche TJ, Chaudhary P. Immunomodulatory Drugs Are Efficacious Against Primary Effusion Lymphoma By Targeting IKZF1, IRF4 and MYC in a CRBN-Dependent Manner and Are Synergistic with BRD4 Inhibitors Blood. 124: 3109-3109. DOI: 10.1182/Blood.V124.21.3109.3109 |
0.537 |
|
| 2013 |
Graham C, Matta H, Yang Y, Yi H, Suo Y, Tolani B, Chaudhary PM. Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation. Journal of Virology. 87: 2242-52. PMID 23236068 DOI: 10.1128/Jvi.01393-12 |
0.57 |
|
| 2012 |
Matta H, Gopalakrishnan R, Graham C, Tolani B, Khanna A, Yi H, Suo Y, Chaudhary PM. Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC. Plos One. 7: e36601. PMID 22590573 DOI: 10.1371/Journal.Pone.0036601 |
0.537 |
|
| Show low-probability matches. |